The Department of Comparative Pathobiology (CPB) in the College of Veterinary Medicine at Purdue University offers graduate programs leading to the Master of Science (MS; thesis or non-thesis) and Doctor of Philosophy (PhD) degrees.
The Department of Comparative Pathobiology in the College of Veterinary Medicine. Purdue University, offers graduate instruction leading to the Master of Science (MS) or Doctor of Philosophy (PhD) degrees to persons possessing the DVM degree and to those with a baccalaureate degree and comprehensive training in the biological sciences. Areas of study include animal welfare science and human-animal interaction, cancer biology, infectious diseases, bacteriology, epidemiology, immunology, laboratory and experimental medicine, parasitology, pathology, public health, toxicology, virology, and molecular genetics.
Earn your MS or PhD in Comparative Pathobiology at Purdue Veterinary Medicine. Study topics like cancer biology, infectious disease, public health, toxicology, and more. Open to DVMs and students with strong biological science backgrounds.
CPB
Pathways to discovery
Get to know us
Find our people
The latest headlines
Get in touch
Navigate your graduate journey
Assistant Professor, Antimicrobial Resistance/Farm Animal Medicine | Purdue Veterinary Hospital Infectious Disease Epidemiologist
Dr. Ilya Slizovskiy is an assistant professor of antimicrobial resistance and farm animal medicine in the Purdue University Veterinary Clinical Sciences Department and is the Purdue University Veterinary Hospital infectious disease Epidemiologist effective February 12, 2024. As a public health veterinarian and microbiologist, Dr. Slizovskiy is dedicated to reducing morbidity and mortality in human and animal populations by addressing antimicrobial resistance (AMR), bacterial virulence, and pathogenicity. Dr. Slizovskiy's Laboratory for Infectious Disease and Antimicrobial Resistance Research develops genomic sequencing, computational, and statistical tools to characterize and predict the risks of AMR dissemination within and across diverse microbial communities (i.e., microbiomes). Over the next 5–10 years, Dr. Slizovskiy aims to expand the lab into a dynamic, collaborative, and innovative research hub. By leveraging insights from microbiome science, the lab seeks to enhance animal welfare and production, guide sustainable land and water use, and advance human health and disease prevention efforts. Currently, the Slizovskiy Lab is focused on developing novel microbiome-based therapeutics, diagnostic and surveillance technologies, and computational platforms that leverage efficient algorithms to process and reveal 'big data' insights.
